Hyperfine, Inc. (HYPR) has a MoatMap StockRank of 30/100 based on Quality (26/100), Value (35/100), and Momentum (57/100) factor scores. The current signal is SELL. Hyperfine's portable MRI technology is highly innovative, but the company is a micro-cap with negative cash flows and lacks the scale, pricing power, or macro tailwinds required for our concentrated portfolio.
Hyperfine, Inc. is a medical device company that develops and commercializes the Swoop® Portable MR Imaging System, the world's first and only FDA-cleared portable magnetic resonance imaging solution. The company's innovative technology significantly reduces the cost and infrastructure requirements of traditional MRI, enabling point-of-care brain imaging in diverse clinical and non-clinical settings. It positions itself as a disruptive force in diagnostic imaging, aiming to expand MRI accessibility globally.
| Price | $1.42 |
| Market Cap | $159M |
| P/E (Forward) | -4.41 |
| Price/Book | 4.30 |
| Return on Equity | -89.8% |
| Return on Invested Capital | -85.2% |
| Debt/Equity | 38.19 |
| Gross Margin | 51.2% |
| Operating Margin | -219.3% |
| Revenue Growth | 82.6% |
| Free Cash Flow | $-16M |
Hyperfine, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).